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a b s t r a c t
Previous studies have provided evidence for a vigilant attentional bias toward threat stimuli and
increased basal diurnal cortisol levels in patients with psychogenic nonepileptic seizures (PNES). Because
cortisol levels may be predictive of threat vigilance, we reanalyzed previous data on threat vigilance in 19
unmedicated patients with PNES and found a positive correlation between baseline cortisol levels and
attentional bias scores for threat stimuli (r = 0.49, P = 0.035). There was no such relationship in healthy
matched controls (n = 20) or in patients with epileptic seizures (n = 17). These ﬁndings provide the ﬁrst
evidence linking an endocrine stress marker to increased threat sensitivity in PNES and support new inte-
grated psychoneurobiological models of PNES.
 2009 Elsevier Inc. All rights reserved.
1. Introduction
Although psychogenic nonepileptic seizures (PNES) are related
by deﬁnition to psychological stress factors [1], little is known
about the cognitive and biological stress sensitivity of patients pre-
senting with PNES. Several studies have indicated that patients
with PNES report higher rates of psychological trauma, such as sex-
ual abuse, compared with healthy controls or controls with epi-
lepsy [see 2 for a review]. In addition, patients with PNES report
more avoidant coping behavior [3–5] and increased fear sensitivity
[6]. However, all these ﬁndings rely on self-reports, and to our
knowledge, only one study has investigated whether PNES are
associated with increased threat sensitivity using an objective
threat processing (reaction time) task. Bakvis et al. [7] found in-
creased threat vigilance, as indicated by an attentional bias for dis-
plays of angry faces in an emotional Stroop task, in individuals
with PNES as compared with matched healthy controls (HC). In
addition, two studies have reported increased basal cortisol levels
in patients with PNES [8,9], one of which indicated that the basal
hypercortisolism was independent of current seizures [9]. Cortisol
may enhance processing of angry faces [10,11] and, although these
ﬁndings are suggestive of a relationship between basal cortisol lev-
els and threat vigilance in patients with PNES, no studies have di-
rectly tested this premise. We reanalyzed previous data on threat
vigilance in 19 unmedicated patients with PNES and related the
previously reported attentional bias (AB) scores for angry faces
[7] to newly analyzed baseline (pretask) cortisol levels. In addition,
we tested the speciﬁcity of eventual effects by investigating the
same relationship in the HC reported in Bakvis et al. [7] and in a
new control group of 17 patients with epileptic seizures (ES). We
predicted that the cortisol levels would be positively correlated
to the enhanced AB scores for angry faces of patients with PNES.
2. Methods
2.1. Participants
Nineteen patients with PNES and 20 HC from the Bakvis et al.
study were included in the study [7]. Patients with PNES who were
being treated at SEIN, Epilepsy Institute in The Netherlands, were
recruited by the attending neurologists. The main inclusion criteria
were (1) diagnosis of PNES based on an ictal video/EEG recording of
a typical seizure and (2) no current use of medication (see Table 1
for demographics, seizure characteristics, and menstrual cycle
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information, and see [7] for detailed inclusion criteria). In addition,
17 patients with ES without suspicion of (a history of) comorbid
PNES based on EEG recording (with or without additional neuroim-
aging data), medical history, seizure semiology, and antiepileptic
drug treatment (AED) experience, who were being treated at SEIN,
were recruited by their neurologist. Sixteen patients with ES had
localization-related epilepsy (11 temporal lobe epilepsy [TLE],
three frontal lobe epilepsy, two uncertain) and one had primary
generalized epilepsy. AED treatment included monotherapy
(n = 15) with carbamazepine (n = 9) or valproic acid (n = 6) and
polytherapy (n = 1) with carbamazepine and clobazam. One patient
was not on AED treatment.
All participants were instructed to minimize physical exercise
during the hour preceding the experiment and to avoid large
meals, coffee, drinks with low pH, and cigarettes, because these
variables can affect cortisol levels. All participants had normal or
corrected-to-normal vision. The study was approved by the local
ethics committee, and all participants provided written informed
consent and received ﬁnancial compensation for participation.
2.2. The emotional Stroop task
The preconscious attentional processing of happy and angry
faces was assessed using a masked pictorial emotional Stroop task
[12]. Facial stimuli of 10 different individuals (5 males, 5 females)
were taken from Ekman and Friesen’s Pictures of Facial Affect [13],
each displaying a neutral, a happy, and an angry expression. The fa-
cial stimuli were presented for 14 ms. Immediately after stimulus
presentation the pictures were replaced by a masking stimulus.
The masking stimuli consisted of randomly cut, reassembled, and
rephotographed pictures of faces. At each trial, the stimulus and
mask were presented in the same color (red, green, or blue), and
participants were instructed to vocalize this color as fast and accu-
rately as possible. On vocal response initiation (timing of which
was registered by means of voice-key registration: reaction time
[RT] in milliseconds), the presentation of the masking stimulus
was terminated. After a random intertrial interval (2–4 seconds),
new trials started with a 750-ms lasting ﬁxation point. A total of
30 happy, 30 angry, and 30 neutral faces were presented in random
order with the restriction that the same color was never repeated
more than twice consecutively. The AB score for angry faces was
based on correct responses only, and calculated by subtracting
the mean individual RTs for neutral face trials from the individual
mean RTs for angry face trials.
2.3. Cortisol
Baseline cortisol was analyzed from saliva sampled approxi-
mately 40 minutes before task administration using Salivette
collection devices (Sarstedt, Rommelsdorf, Germany). Saliva sam-
ples were stored at 20 C before assaying. Biochemical analysis
of free cortisol in saliva was performed using a competitive electro-
chemiluminescence immunoassay (ECLIA, Elecsys 2010, Roche
Diagnostics), as described elsewhere [14].
2.4. Statistical testing
Group differences in AB scores were analyzed using statistical
analyses of variance (ANOVA), and subsequent least-signiﬁcant-
difference (LSD) planned comparisons were calculated to further
detail group differences. Correlations between baseline cortisol
and AB scores were calculated using Pearson’s correlations. Given
the strong directedness of the hypotheses for the AB scores, group
differences in AB scores were tested one-tailed; the other analyses
were two-tailed (a = 0.05). Effect sizes of signiﬁcant results are
reported using partial eta squared (g2). Because groups differed
with respect to age (see Table 1), we controlled for age by subse-
quently adding it as a covariate into the group ANOVA for the AB
scores. Because groups differed with respect to use of contracep-
tives by women (see Table 1), we controlled for this variable in
case of signiﬁcant effects involving cortisol (using partial
correlations).
3. Results
One-way ANOVA for the AB scores for angry faces, with group
(HC, PNES, ES) as between-subject factor, indicated signiﬁcant
group differences: F(2,56) = 2.85, P = 0.033, one-tailed; g2 = 0.097
(Fig. 1). This effect remained when controlling for age (age added
as a covariate to the analysis): F(3,56) = 2.80, P = 0.035,
g2 = 0.097. LSD planned comparisons indicated signiﬁcant differ-
ences for patients with PNES versus those with ES (P = 0.032) and
versus HC (P = 0.016), but not for patients with ES versus HC
(P = 0.42). Groups did not differ with respect to their baseline cor-
tisol levels (HC: M = 6.7, SD = 2.80; PNES: M = 6.9, SD = 2.96; ES:
M = 5.7, SD = 3.10; F(2,55) = 0.95, P = 0.39), but, as expected, within
the PNES group we found a signiﬁcant positive correlation between
the AB score for angry faces and baseline cortisol levels (r = 0.49,
P = 0.035) (see Fig. 2). This effect remained when controlling for
menstrual cycle (r = 0.49, P = 0.039) and use of contraceptives
Table 1
Group characteristics.
Variable Healthy
controls
group
(N = 20)
Patients
with
PNES
(N = 19)
Patients
with
epileptic
seizures
(N = 17)
Statistics
Age 22.1 (4.2) 27.6 (7.3) 42.4 (12.9) F(2,56) = 26.6,
P < 0.001
Number of women 18 15 11 v2(2) = 3.5,
P = 0.17
Number of women
using
contraceptivesa
10 6 1 v2(2) = 6.1,
P < 0.05
Number of women
in luteal phaseb
8 7 4 v2(2) = 0.48,
P = 0.79
Age at onset, years 21.1 (7.9) 20.7 (15.1) F(1,34) = 0.01,
P = 0.93
Disease duration,
years
6.5 (7.4) 21.7 (15.7) F(1,34) = 14.23,
P < 0.01
a Use of contraceptive was unknown in one patient with PNES.
b Menstruation cycle was indeterminable in two patients with PNES and one
healthy control.
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Fig. 1. Attentional bias (AB) scores for angry faces (reaction time [RT] in angry face
trials  RT in neutral face trials) for healthy controls (HC), patients with psycho-
genic nonepileptic seizures (PNES), and patients with epileptic seizures (ES).
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(r = 0.49, P = 0.037) by means of partial correlations. There was no
such relationship for the HC (r = 0.001, p = 0.99) or ES (r = 0.07,
P = 0.84) control group for angry faces, and there were no such
relationships for happy faces in all groups (all P > 0.64). Finally,
we tested whether the reported correlations between baseline cor-
tisol levels and AB scores for angry faces differed signiﬁcantly be-
tween the PNES and control groups. We used Fisher’s r-to-r0
transformation to normalize the distribution of correlation coefﬁ-
cients, which allows the use of a Z test to compare the correlations.
Comparison of the correlations for patients with PNES with those
for ES controls revealed a signiﬁcant difference, as indicated by a
Z score (for independent groups, see [15]) of 1.64 (P = 0.05) and
the PNES–HC comparison showed a trend toward signiﬁcance,
with Z = 1.52 (P = 0.064).
4. Discussion
This study showed that baseline (pretask) cortisol levels were
positively correlated to threat vigilance in 19 unmedicated patients
with PNES. These effects remained when controlling for use of con-
traceptives and menstrual cycle. The effects were speciﬁc for PNES
and were absent for control groups consisting of healthy individu-
als and patients with ES, respectively. The relationship between
baseline cortisol and threat vigilance in patients with PNES in
our study is relevant in the light of recent observations of increased
basal cortisol levels in patients with PNES [8,9] and may contribute
to our insight into possible stress factors implicated in the in-
creased threat vigilance in PNES. According to cognitive theories
of medically unexplained symptoms (MUS) [16] and more recent
integrated psychoneurobiological theories of MUS [2], increased
activity in neurobiological stress systems and increased attention
to threat make part of a state of hypervigilance that, in turn, may
play a crucial role in the presence of MUS as well as dissociative
symptoms [7,9]. In addition, increased threat vigilance on a
masked emotional Stroop task [17], as well as hypercortisolism
[18], has been reported for patients with a primary diagnosis of
dissociative disorder as well. Taken together, these and previous
ﬁndings in PNES show great overlap with previous ﬁndings in pa-
tients with a dissociative disorder. Although the ﬁndings need to
be replicated, preferably in larger patient samples, the present re-
sults provide the ﬁrst evidence of a direct relationship between the
biological stress marker cortisol and cognitive threat sensitivity in
PNES and provide a starting point, as well as preliminary support,
for integrated psychoneurobiological theories for this complex dis-
order [2]. If replicated, these ﬁndings, together with evidence for
increased basal cortisol levels in PNES [9], may help to ﬁne-tune
psychological as well as pharmacological interventions for PNES
[19].
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